Dermatitis due to substances taken internally

MESH PheWeb

L12_INTERNALSUBSTANCEDERM

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 L27

Hospital discharge: ICD-9 693

Hospital discharge: ICD-8 $!$

Hospital discharge: excluded ICD-9 L272

Cause of death: ICD-10 L27

Cause of death: ICD-9 693

Cause of death: ICD-8 $!$

Cause of death: excluded ICD-9 L272

2025

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1939

Check minimum number of events None

1939

Include endpoints None

1939

L12_INTERNALSUBSTANCEDERM

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 L20-L30

Name in latin Dermatitis e substantiis devoratis

Similar endpoints

↥

List of similar endpoints to Dermatitis due to substances taken internally based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1870	1198	672
Unadjusted prevalence (%)	0.61	0.69	0.50
Mean age at first event (years)	34.69	34.74	34.61

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	4.20 [2.72, 6.50]	1.1e-10	130
15 years	0.01	1.94 [1.35, 2.79]	3.1e-4	47
5 years	0.01	4.44 [3.06, 6.43]	3.5e-15	45
1 year	0.00	12.27 [7.72, 19.49]	2.6e-26	26

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Dermatitis due to substances taken internally
after Dermatitis due to substances taken internally

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Dermatitis due to substances taken internally

↥